WHAT'S NEW

March 01, 2021, Vilnius -
Delta biosciences accepted the European Union's call for COVID-related R&D. We are thus working on an EU-backed project "Molecular synthesis and primary screening assay platform R&D for anti-COVID drug discovery and pre-clinical research", in partnership with Postera AI, a high-growth US startup leveraging machine learning to provide Medicinal Chemistry as a Service.

Together, the team is aiming to synthesise and field-test a potent SARS-CoV-2 MPro inhibitor, as part of an international open science, crowdsourced "COVID Moonshot" initiative to accelerate the development of a COVID antiviral.